| Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396) (NCT00650689) | Organon and Co | 2003-05-01 |
| Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS) (NCT00660764) | AstraZeneca | 2003-05-01 |
| Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP) (NCT00653965) | AstraZeneca | 2003-05-01 |
| Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED) (NCT00092612) | Organon and Co | 2003-05-01 |
| An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED) (NCT00092638) | Organon and Co | 2003-05-01 |
| Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks (NCT00653588) | AstraZeneca | 2003-04-01 |
| Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476) (NCT00651274) | Organon and Co | 2003-04-01 |
| Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED) (NCT00092573) | Organon and Co | 2003-04-01 |
| Pravastatin and Protease Inhibitors in HIV-infected Patients (NCT00221754) | University Hospital, Bordeaux | 2003-03-01 |
| Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317) (NCT00651144) | Organon and Co | 2003-03-01 |
| Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803) (NCT00092625) | Organon and Co | 2003-03-01 |
| Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease (NCT00144937) | Hospital de Sabadell | 2003-03-01 |
| Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801) (NCT00092599) | Organon and Co | 2003-02-01 |
| Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET) (NCT00396110) | AstraZeneca | 2003-02-01 |
| Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia (NCT00240357) | AstraZeneca | 2003-02-01 |
| The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study (NCT00240279) | AstraZeneca | 2003-01-01 |
| An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED) (NCT00092664) | Organon and Co | 2003-01-01 |
| Safety and Effectiveness of Flaxseed for Reducing High Cholesterol (NCT00051415) | National Center for Complementary and Integrative Health (NCCIH) | 2003-01-01 |
| Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin (NCT02591836) | NeuroBo Pharmaceuticals Inc. | 2003-01-01 |
| A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED) (NCT00092846) | Merck Sharp & Dohme LLC | 2002-12-04 |
| Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver Disease (NCT00529178) | Bristol-Myers Squibb | 2002-12-01 |
| Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) (NCT00092560) | Organon and Co | 2002-12-01 |
| A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks. (NCT00754507) | Daiichi Sankyo | 2002-11-01 |
| A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks. (NCT00755352) | Daiichi Sankyo | 2002-11-01 |
| A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Simvastatin for at Least 4 Weeks. (NCT00753779) | Daiichi Sankyo | 2002-11-01 |
| Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients? (NCT00704314) | Medical University of Vienna | 2002-10-01 |
| Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) (NCT00654225) | AstraZeneca | 2002-10-01 |
| Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040) (NCT00092586) | Organon and Co | 2002-09-01 |
| Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice (NCT01242319) | Memorial Hospital of Rhode Island | 2002-09-01 |
| A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038) (NCT00092651) | Organon and Co | 2002-09-01 |
| Guideline Adherence for Heart Health (NCT00224848) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-07-01 |
| Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR) (NCT00654173) | AstraZeneca | 2002-06-01 |
| Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) (NCT00552097) | Organon and Co | 2002-06-01 |
| The Effect of Fasudil on Vascular Function in Humans (NCT00120718) | Brigham and Women's Hospital | 2002-06-01 |
| Comparative Atorvastatin Pleiotropic Effects (NCT00163202) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-06-01 |
| Biological CVD Risk Factors in Older Depressed Patients (NCT00318864) | Stanford University | 2002-06-01 |
| The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia (NCT00329069) | University of Ulm | 2002-05-01 |
| Comparing Effects of 3 Sources of Garlic on Cholesterol Levels (NCT00056511) | National Center for Complementary and Integrative Health (NCCIH) | 2002-05-01 |
| Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025) (NCT00092716) | Organon and Co | 2002-05-01 |
| Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224) (NCT00092157) | Organon and Co | 2002-05-01 |
| Effect of a Community-based Nursing Intervention on Mortality in Chronically Ill Older Adults (NCT01071967) | Health Quality Partners | 2002-04-01 |
| Effects of Black Tea Intake on Serum Lipids (NCT01882283) | University of Minnesota | 2002-04-01 |
| Cholesterol and Pharmacogenetic Study (NCT00451828) | UCSF Benioff Children's Hospital Oakland | 2002-03-01 |
| Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) (NCT00653744) | AstraZeneca | 2002-03-01 |
| Rosuvastatin ORBITAL Germany (NCT00379249) | AstraZeneca | 2002-02-01 |
| Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin (NCT00385931) | Novartis | 2002-01-01 |
| Garlic in Hyperlipidemia Caused by HAART (NCT00029250) | National Center for Complementary and Integrative Health (NCCIH) | 2001-11-01 |
| Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia (NCT00654407) | AstraZeneca | 2001-11-01 |
| Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD (NCT00037401) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-09-01 |
| Soybean Based Diets and CVD Risk Factors (NCT00175097) | Tufts University | 2001-06-01 |
| Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia (NCT00005313) | University of Washington | 2001-04-01 |
| STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges (NCT00654537) | AstraZeneca | 2001-04-01 |
| Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017) (NCT03882892) | Organon and Co | 2001-02-02 |
| Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019) (NCT03885921) | Organon and Co | 2000-10-25 |
| A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032) (NCT03882996) | Organon and Co | 2000-10-06 |
| Cholesterol-Lowering Effects of Policosanol (NCT00288483) | Drug Commission of the German Medical Association | 2000-09-01 |
| Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy (NCT02571257) | NeuroBo Pharmaceuticals Inc. | 2000-08-01 |
| Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High Cholesterol (NCT00006071) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-07-01 |
| Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers (NCT02587390) | NeuroBo Pharmaceuticals Inc. | 2000-05-01 |
| Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030) (NCT03867318) | Organon and Co | 2000-04-24 |
| An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013) (NCT03867110) | Organon and Co | 2000-03-06 |
| Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model (NCT00074633) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-01-01 |
| Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects (NCT00654394) | AstraZeneca | 2000-01-01 |
| Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides (NCT02585869) | NeuroBo Pharmaceuticals Inc. | 1999-12-01 |
| Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects (NCT00001963) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-12-01 |
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) (NCT00000620) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-09-01 |
| Weight Loss Associated With the Consumption of Apple (NCT01723007) | Universidade Federal do Amazonas | 1999-08-01 |
| Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers (NCT02587364) | NeuroBo Pharmaceuticals Inc. | 1999-04-01 |
| Influence of Simvastatin on Apolipoprotein B-100 (apoB-100) Secretion (NCT00905541) | University Hospital, Bonn | 1998-11-01 |
| Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women (NCT00001752) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-09-01 |
| Primary Prevention of CHD Risk Factors Occurring in US (NCT00005495) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-07-01 |
| The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic Patients (NCT00001742) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-02-01 |
| Study of the Response of Human Small Blood Vessels (NCT00001622) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-03-01 |
| Precursors of CVD Risk Factors--Project Heartbeat (NCT00005478) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin (NCT01057654) | University Hospital, Bonn | 1996-01-01 |
| Potential Risk Factors for Stroke (NCT00001368) | National Institute of Neurological Disorders and Stroke (NINDS) | 1993-10-01 |
| Evaluation of Childhood Blood Pressure and Lipid Screening (NCT00005439) | National Heart, Lung, and Blood Institute (NHLBI) | 1992-04-01 |
| Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause (NCT00000532) | National Heart, Lung, and Blood Institute (NHLBI) | 1992-02-01 |
| Diet and Exercise for Elevated Risk (DEER) (NCT00000598) | Stanford University | 1991-08-01 |
| Population-Based Modeling of Cholesterol Lowering in the United States (NCT00005463) | National Heart, Lung, and Blood Institute (NHLBI) | 1991-08-01 |
| Evaluating Strategies to Control Hypercholesterolemia (NCT00005350) | National Bureau of Economic Research, Inc. | 1991-04-01 |
| Dietary Treatment of Hyperlipidemia in Women vs. Men (NCT00005336) | University of Washington | 1991-04-01 |
| Lipid Variability--Influence of Stress (NCT00005468) | National Heart, Lung, and Blood Institute (NHLBI) | 1990-07-01 |
| Cholesterol Reduction in Seniors Program (CRISP) (NCT00000477) | National Heart, Lung, and Blood Institute (NHLBI) | 1990-07-01 |
| Diet and Plasma Cholesterol - Secular Trend Analysis (NCT00005257) | National Heart, Lung, and Blood Institute (NHLBI) | 1990-05-01 |
| Evaluation of Cholesterol Education for At-Risk Children (NCT00005718) | National Heart, Lung, and Blood Institute (NHLBI) | 1990-04-01 |
| Lifestyle Heart Trial (NCT00000471) | National Heart, Lung, and Blood Institute (NHLBI) | 1989-04-01 |
| Strong Heart Study (NCT00005134) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-09-01 |
| Postmenopausal Estrogen/Progestin Interventions (PEPI) (NCT00000466) | National Heart, Lung, and Blood Institute (NHLBI) | 1987-09-01 |
| Sex Steroids, Obesity and Lipids in Adolescent Females (NCT00005210) | National Heart, Lung, and Blood Institute (NHLBI) | 1987-09-01 |
| Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia (NCT00005203) | University of Washington | 1987-07-01 |
| Dietary Intervention Study in Children (DISC) (NCT00000459) | National Heart, Lung, and Blood Institute (NHLBI) | 1986-12-01 |
| Study of Children's Activity and Nutrition (SCAN) (NCT00005178) | Augusta University | 1985-09-01 |
| Pawtucket Heart Health Program (NCT00005151) | National Heart, Lung, and Blood Institute (NHLBI) | 1980-08-01 |
| Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins (NCT00001154) | National Heart, Lung, and Blood Institute (NHLBI) | 1976-09-03 |
| Magnetic Resonance Imaging-Portfolio Diet Study #7 (NCT02078635) | Unity Health Toronto | |
| Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST (NCT00082251) | Kos Pharmaceuticals | |
| The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A (NCT00004564) | National Center for Research Resources (NCRR) | |
| Impact of Consumption of Oats in Lipid Profile of Children and Adolescents With Dyslipidemia (NCT01581697) | Instituto de Cardiologia do Rio Grande do Sul | |
| Rosuvastatin and Renal Endothelial Function (NCT00160745) | University of Erlangen-Nürnberg Medical School | |